PCPC, CHPA Urge 'Modern' Risk Assessments For Sunscreen Ingredients
This article was originally published in The Rose Sheet
FDA should revise its draft guidance on OTC sunscreen GRASE data to reflect modern toxicological risk assessment, say the Personal Care Products Council and Consumer Healthcare Products Association in a joint comment. The groups ask the agency to meet to discuss current approaches.
You may also be interested in...
PASS Coalition fails to find common ground with US FDA as the sunscreen access advocacy group urges significant changes to a draft guidance on safety testing for sunscreen ingredients.
ChromaDex Corp. agrees to supply its ‘healthy aging’ nicotinamide riboside ingredient Niagen to New York-based healthcare technology firm Roman Health Ventures, Inc., which plans to use it in its men’s supplement line. ChromaDex’ total sales in the first quarter rose 2% to $14.7m.
Less travel, closed schools and a slower cold/cough season during the pandemic required Prestige Consumer to invest strategically across its OTC healthcare portfolio in fiscal 2021. Dramamine motion sickness and Nix head lice treatments got less attention, while Monistat, Compound W and Clear Eyes received more.